ImmuCell Corporation
No trades
No trades
Fundamentals and stats
EPS and revenue snapshot
In the last quarter, the company reported −0.01 USD per share, beating the −0.01 USD estimate by 0.00%. Revenue for the same period reached 5.40 M USD, despite the estimate of 5.40 M USD.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise